CLINICAL_TRIALS
trial_result
· 2020-07-20
Clinical Trial Update: Collection of Blood Samples From Patients With Relapsing MS Who Developed ITP After Receiving Lemtrada [Phase 4]
Summary
Phase 4 trial update collecting blood samples from relapsing MS patients who developed ITP after Lemtrada; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Genzyme, a Sanofi Company | Conditions: Multiple Sclerosis | Phase 4 | Status: COMPLETED | Results posted: 2020-07-20